MARKETS
Company

ABVC BioPharma Postpones Biokey (Cayman) Share Distribution, Rescheduled For August 21, 2026

Aug 12, 2026 · 12:06 PM ET· updated 1h ago

On August 3, 2026, ABVC BioPharma, Inc. (the "Company") determined to postpone the previously announced distribution of ordinary shares of BioKey (Cayman), Inc. (the "Distribution"), which had been

Share
Why It Matters

ABVC BioPharma pushed back its plan to give shareholders (owners) pieces of another company called BioKey to a later date. When companies delay plans like this, it's worth watching to see if there are any problems or if things are just taking longer than expected.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.